Beyond Type 1 Funding Model


One hundred percent of operational expenses of Beyond Type 1 are covered by our Founders, Founding Friends, and select corporate partners in an effort to maximize the impact of community support and enhance transparency. One hundred percent of donations from the community directly fund Beyond Type 1’s portfolio of curated programs and grants, making a direct and immediate impact in the lives of people living with Type 1 diabetes. 

This policy allows us to engage with partners that further our mission – to educate, advocate and ultimately find a cure for Type 1. To avoid a potential conflict of interest specifically around the issue of insulin pricing, Beyond Type 1 maintains an organizational policy not to accept cash contributions from insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi.

The Beyond Type 1 Board of Directors further abide by a Conflict of Interest policy that is reviewed annually. The Beyond Type 1 Conflict of Interest policy, along with annual tax filings and audited financial statements are available by request.

Beyond Type 1 is a 501(c)(3) tax-exempt nonprofit organization, under charitable ID #47-3336640.